As part of the America Invents Act of 2012, trial proceedings before the Patent Trial and Appeal Board (PTAB) have become a powerful tool for challenging existing patents.
Honigman attorneys in the Patent Office Trials Practice Group have handled some of the very first inter partes review (IPR) trials before the Patent Trial and Appeal Board (PTAB), giving us first-hand knowledge of the most effective strategies for both patent owners and petitioners.
Honigman’s Patent Office Trials Practice Group is comprised of more than two dozen registered patent attorneys who possess the deep technical knowledge necessary to handle complex cases before the PTAB.
Representative cases handled by our attorneys include:
- Represented a branded pharmaceutical company in the first-ever successful defense of a pharmaceutical patent in an AIA review; after the oral hearing, the PTAB ruled that a generic challenger had not proven that claims in three related patents covering controlled release formulations were unpatentable for obviousness over the prior art
- Represented a branded pharmaceutical company in an IPR where the validity of a patent covering an anti-nausea drug patent was challenged by a generic ANDA filer; after filing of the preliminary patent owner response, the PTAB decided not to review the patent
- Representing a medical device company in eight IPRs involving client’s patents covering medical imaging technology
News & Resources
- Pharmaceutical Patent Invalidity Challenge Score Card: District Courts v. The PTAB, 10th Annual Paragraph IV Disputes, American Conference Institute (ACI), New York, NYApril 25-26, 2016